Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic Nephropathy
NCT04981613
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Nephropathy
Interventions
DRUG:
Kunxian capsule
Sponsor
First Affiliated Hospital Xi'an Jiaotong University